Table 3.
Secondary outcomes | Restrictive transfusion group n=112 (%) | Liberal transfusion group n=112 (%) | P |
---|---|---|---|
Packed cells transfused | 1.72±1.38 | 1.96±1.54 | 0.22* |
FFP transfused | 1.04±2.45 | 1.57±2.62 | 0.12* |
In-hospital bleeding (%) | 12 (10.71) | 9 (8) | 0.25† |
Bleeding during follow up (%) | 13 (12.26) | 14 (13.21) | 0.84† |
Banding (%) | 37 (62) | 39 (81) | 0.99† |
Sclerosant (%) | 4 (7) | 4 (8) | 1.00† |
Sengstaken Blakemore tube placement (%) | 4 (3.6) | 9 (8) | 0.29† |
Propranolol (%) | 20 (33.3) | 19 (39.6) | 0.25† |
Octreotide (%) | 35 (31.25) | 50 (44.64) | 0.04† |
Duration of octreotide (days) | 2.49±0.82 | 2.16±0.77 | 0.33* |
Mean length of admission (days) | 3.21±2.78 | 2.73±1.29 | 0.10* |
Mean Hb at the time of death (g/dl) | 7.17±1.85 | 5.27±2.71 | 0.19* |
FFP: fresh frozen plasma; Hb: Hemoglobin; *independent t-test; †Chi-square test